G1 Therapeutics, Inc. IPO Research Information

G1 Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on G1 Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
G1 Therapeutics, Inc.	GTHX - NASDAQ	$15.00-$17.00	$15.00	$15.00	7 million	5/17/2017
Underwriter(s): J.P. Morgan, Cowen and Company
Co-Manager(s): Needham & Company, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2017-04-13 Terms Added 2017-05-08

G1 Therapeutics, Inc. Quote & Chart - Click for current quote - GTHX

About G1 Therapeutics, Inc. (adapted from G1 Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GTHX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.